Skip to main content

Table 1 The demographic and clinical characteristics of the participants

From: MALBAC-based chromosomal imbalance analysis: a novel technique enabling effective non-invasive diagnosis and monitoring of bladder cancer

 

Training Group

Validation Group

 

BC

UD

NC

BC

UD

NC

Total No.

74

23

51

120

15

45

No. gender (%)

 Female

7 (9.5)

8 (34.8)

15 (29.4)

21(17.5)

5(33.3)

9 (20)

 Male

67 (90.5)

15 (65.2)

36 (70.6)

99(82.5)

10(66.7)

36 (80)

Median age (range)

62 (28–90)

56 (18–72)

41 (23–69)

62(33–93)

54(22–73)

40(21–66)

Primary (%)

61 (82.4)

106(88.3)

Recurrent (%)

13 (17.6)

14(11.7)

No. tumour stage (%)

 Tis

1 (1.4)

2(1.7)

 Ta

23 (31.1)

34(28.3)

 T1

24 (32.4)

61(50.8)

 T2

16 (21.6)

13(10.8)

 T3

5 (6.8)

10(8.3)

 NA

5 (6.8)

0(0.0)

No. tumour grade (%)

 PUNLMP

5(6.8)

0(0.0)

 LG

9(12.2)

33(27.5)

 HG

59 (79.7)

83(69.2)

 NA

1 (1.4)

4(3.3)

  1. BC bladder cancer patients, UD non-malignant urinary disease patients, NC healthy participants